Conference “Polish Healthcare Assets Sector #PHASE2024” – THE LARGEST DISCUSSION ON POLISH BIOTECHNOLOGY!

On August 27-29, 2024, representatives of the Silesian Park of Medical Technology Kardio-Med Silesia are participating in the #PHASE2024 conference.

• PHASE#2024 brought together 70 representatives from the medical biotechnology ecosystem, including representatives from over 20 companies in the sector, public administration, the capital market, and academia. The program includes 17 discussion panels, interviews, and lectures, with distinguished specialists from Poland and abroad participating, including two special guests: Cailin M. from Morgan Stanley and Nektarios (Aris) Oraiopoulos from the University of Cambridge, who will deliver lectures and participate in debates.
• PHASE#2024 is a platform for discussing Polish medical biotechnology as one of Poland’s smart specializations, which can and should develop dynamically within the current EU financial perspective.
• Participants in the panel discussions include representatives from: MRIT, MF, ARP, ABM, NCBIR, PARP.

Strategic partners of the event include the Warsaw Stock Exchange (GPW), mBank S.A., and the Polish Development Fund S.A.

We congratulate the organizers: BioInMed, Blume Advisory, and Strefa Inwestorów, on this important event for the entire biotechnology industry!